Strs Ohio boosted its position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO – Get Rating) by 418.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 8,300 shares of the company’s stock after buying an additional 6,700 shares during the quarter. Strs Ohio’s holdings in Alpha Teknova were worth $27,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of TKNO. Millennium Management LLC boosted its stake in Alpha Teknova by 100.4% during the second quarter. Millennium Management LLC now owns 656,981 shares of the company’s stock worth $5,519,000 after buying an additional 329,213 shares during the period. Wellington Management Group LLP boosted its stake in Alpha Teknova by 27.7% during the first quarter. Wellington Management Group LLP now owns 1,333,638 shares of the company’s stock worth $18,418,000 after buying an additional 289,433 shares during the period. Russell Investments Group Ltd. purchased a new position in Alpha Teknova during the second quarter worth $1,654,000. Conestoga Capital Advisors LLC boosted its stake in Alpha Teknova by 85.1% during the third quarter. Conestoga Capital Advisors LLC now owns 196,149 shares of the company’s stock worth $655,000 after buying an additional 90,200 shares during the period. Finally, Platinum Investment Management Ltd. boosted its stake in Alpha Teknova by 41.6% during the second quarter. Platinum Investment Management Ltd. now owns 239,594 shares of the company’s stock worth $2,013,000 after buying an additional 70,357 shares during the period. 22.74% of the stock is owned by hedge funds and other institutional investors.
Alpha Teknova Stock Up 3.0 %
Shares of TKNO opened at $5.91 on Monday. The company has a current ratio of 5.68, a quick ratio of 4.85 and a debt-to-equity ratio of 0.15. The firm has a fifty day moving average price of $5.13 and a 200-day moving average price of $5.03. The firm has a market capitalization of $166.01 million, a P/E ratio of -4.38 and a beta of 0.22. Alpha Teknova, Inc. has a 12-month low of $3.02 and a 12-month high of $18.34.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on TKNO. Cowen lowered their target price on shares of Alpha Teknova from $13.00 to $8.00 in a research note on Thursday, November 10th. Cowen lowered their target price on shares of Alpha Teknova from $13.00 to $8.00 in a research note on Thursday, November 10th. Finally, Stephens lowered their target price on shares of Alpha Teknova to $12.00 in a research note on Wednesday, November 16th.
Alpha Teknova Company Profile
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- CVS Health is Growing into an Integrated Healthcare Organization
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.